Calamos Advisors LLC Takes Position in Lifevantage Corporation (NASDAQ:LFVN)

Calamos Advisors LLC acquired a new position in shares of Lifevantage Corporation (NASDAQ:LFVN - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 33,576 shares of the company's stock, valued at approximately $490,000. Calamos Advisors LLC owned 0.27% of Lifevantage at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in LFVN. Cannon Global Investment Management LLC acquired a new position in shares of Lifevantage in the first quarter worth about $156,000. Cambridge Investment Research Advisors Inc. increased its stake in shares of Lifevantage by 23.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company's stock valued at $188,000 after purchasing an additional 2,421 shares in the last quarter. Hillsdale Investment Management Inc. boosted its position in Lifevantage by 7.3% during the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock worth $258,000 after purchasing an additional 1,000 shares in the last quarter. Schonfeld Strategic Advisors LLC purchased a new position in Lifevantage during the fourth quarter worth approximately $282,000. Finally, OMERS ADMINISTRATION Corp acquired a new stake in Lifevantage in the fourth quarter valued at approximately $284,000. 35.32% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CFO Carl Aure sold 2,746 shares of the business's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total value of $36,768.94. Following the sale, the chief financial officer owned 133,303 shares in the company, valued at approximately $1,784,927.17. The trade was a 2.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 20.65% of the company's stock.

Lifevantage Trading Down 0.9%

LFVN traded down $0.13 during midday trading on Monday, hitting $13.59. 133,040 shares of the company traded hands, compared to its average volume of 155,382. The business has a 50 day simple moving average of $12.56 and a two-hundred day simple moving average of $15.91. Lifevantage Corporation has a 52-week low of $5.22 and a 52-week high of $27.38. The company has a market capitalization of $171.10 million, a price-to-earnings ratio of 19.70 and a beta of 0.43.

Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. The firm had revenue of $58.44 million during the quarter, compared to analyst estimates of $60.99 million. Lifevantage had a net margin of 4.12% and a return on equity of 34.67%.

Lifevantage Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were given a dividend of $0.045 per share. The ex-dividend date of this dividend was Friday, May 30th. This is a boost from Lifevantage's previous quarterly dividend of $0.04. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.32%. Lifevantage's dividend payout ratio (DPR) is currently 26.09%.

Lifevantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.